Stereoselective oxidation metabolism of 20(S)-protopanaxatriol in human liver microsomes and in rats

被引:12
作者
Wang, Wenyan [1 ]
Ni, Yingying [1 ]
Wang, Li [1 ]
Che, Xin [1 ]
Liu, Wanhui [1 ]
Meng, Qingguo [1 ]
机构
[1] Yantai Univ, Sch Pharm, Yantai 264005, Peoples R China
基金
中国国家自然科学基金;
关键词
20(S)-Protopanaxatriol; enzyme kinetics; liver microsomes; metabolite identification; P450; isoforms; stereoselectivity; HUMAN CYTOCHROME-P450 ENZYMES; MICROBIAL TRANSFORMATION; INTESTINAL BACTERIA; MASS-SPECTROMETRY; FATTY-ACID; IN-VITRO; PROTOPANAXATRIOL; GINSENOSIDE; IDENTIFICATION; ENANTIOMERS;
D O I
10.3109/00498254.2014.986562
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. In this study, the oxidative metabolites of 20(S)-protopanaxatriol (PPT) were identified in human liver microsomes (HLMs) and in rats using liquid chromatography-electrospray ionization tandem mass spectrometry. 2. Twelve oxidative metabolites were found in HLM, eight of which have not been previously reported. Twenty-four oxidative metabolites were found in rat feces after oral administration and 20 of these, including six found in HLM, were first reported. The results indicated PPT was more extensively metabolized in rats than in HLM. C20-24 epoxides, a pair of epimers (namely, M1-1 and M1-2) were the major metabolites, and other metabolites were derived from their further metabolism. 3. Enzyme kinetics experiments showed that the apparent formation V-max of M1-1 was 10.4 folds and 2.4 folds higher than that of M1-2 in HLM and in rat liver microsomes (RLMs), respectively. The depletion rate of M1-2 was 11.0 folds faster than M1-1 in HLM, and was similar in RLM. Hence, the remarkable species differences of PPT metabolism mainly resulted from the stereoselective formation and further metabolic elimination of M1-1 and M1-2. 4. Chemical inhibition study and recombinant human P450 isoforms analysis showed that CYP3A4 was the predominant isoform involved in the oxidative metabolism of M1-1 and M1-2.
引用
收藏
页码:385 / 395
页数:11
相关论文
共 29 条
[1]   Microbial transformation of 20(S)-protopanaxatriol by Absidia corymbifera and their cytotoxic activities against two human prostate cancer cell lines [J].
Chen, Guangtong ;
Yang, Xue ;
Zhai, Xuguang ;
Yang, Min .
BIOTECHNOLOGY LETTERS, 2013, 35 (01) :91-95
[2]   Identification of human cytochrome P450 enzymes involved in the hepatic and intestinal biotransformation of 20(S)-protopanaxadiol [J].
Chiu, Nga Ting Colette ;
Guns, Emma S. Tomlinson ;
Adomat, Hans ;
Jia, William ;
Deb, Subrata .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2014, 35 (02) :104-118
[3]  
Evans DC, 2005, CURR OPIN DRUG DISC, V8, P44
[4]  
Han B, 2011, ARZNEIMITTELFORSCH, V61, P148, DOI 10.1055/s-0031-1296181
[5]   Ginsenoside 20(S)-protopanaxatriol (PPT) activates peroxisome proliferator-activated receptor γ (PPARγ) in 3T3-L1 adipocytes [J].
Han, KL ;
Jung, MH ;
Sohn, JH ;
Hwang, JK .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2006, 29 (01) :110-113
[6]   Microsomal Cytochrome P450-Mediated Metabolism of Protopanaxatriol Ginsenosides: Metabolite Profile, Reaction Phenotyping, and Structure-Metabolism Relationship [J].
Hao, Haiping ;
Lai, Li ;
Zheng, Chaonan ;
Wang, Qiong ;
Yu, Guo ;
Zhou, Xueyan ;
Wu, Liang ;
Gong, Ping ;
Wang, Guangji .
DRUG METABOLISM AND DISPOSITION, 2010, 38 (10) :1731-1739
[7]   Inhibitory effect of protopanaxatriol ginseng metabolite M4 on the production of corticosteroids in ACTH-stimulated bovine adrenal fasciculata cells [J].
Hasegawa, Eri ;
Nakagawa, Saori ;
Miyate, Yoshikazu ;
Takahashi, Katsuo ;
Ohta, Shin ;
Tachikawa, Eiichi ;
Yamato, Susumu .
LIFE SCIENCES, 2013, 92 (12) :687-693
[8]   Main Ginseng saponin metabolites formed by intestinal bacteria [J].
Hasegawa, H ;
Sung, JH ;
Matsumiya, S ;
Uchiyama, M .
PLANTA MEDICA, 1996, 62 (05) :453-457
[9]   Proof of the mysterious efficacy of ginseng: Basic and clinical trials: Metabolic activation of ginsenoside: Deglycosylation by intestinal bacteria and esterification with fatty acid [J].
Hasegawa, H .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 95 (02) :153-157
[10]   Prevention of growth and metastasis of murine melanoma through enhanced natural-killer cytotoxicity by fatty acid-conjugate of protopanaxatriol [J].
Hasegawa, H ;
Suzuki, R ;
Nagaoka, T ;
Tezuka, Y ;
Kadota, S ;
Saiki, I .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (07) :861-866